Carvalho Maria, Almeida Isabel F
Professional Compounding Centers of America (PCCA), Department of Research & Development, Houston, TX 77099, USA.
UCIBIO-REQUIMTE, MedTech, Laboratory of Pharmaceutical Technology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
Pharmaceuticals (Basel). 2022 Aug 31;15(9):1091. doi: 10.3390/ph15091091.
Pharmaceutical compounding is an important component of pharmacy practice despite its low prevalence. Several therapeutic needs can be met by a compounded medicine such as dosing adjusted for pediatric patients, special drug combinations, medicines for patients allergic to a given excipient, and medicines for orphan drugs not provided by the pharmaceutical industry. Examples of such applications are provided in this review. Adherence to medication is a critical public health issue as nonadherence to pharmacotherapy has been associated with adverse outcomes and higher costs of patient care. Adherence to therapy represents a key factor in the reduction in morbidity and mortality and optimization of the use of financial resources. The role of pharmaceutical compounding in promoting medication adherence is underexploited. The customization might represent a positive reinforcement of the initiation of the treatment, while implementation and persistence might also be favored in a pharmacy setting. However, studies addressing the influence of compounding in adherence promotion are lacking in the literature. The results of such studies could support health policies including proper regulatory framework, pharmacist training, and information to health care practitioners.
尽管药物配制的应用并不普遍,但它仍是药学实践的重要组成部分。配制药物可以满足多种治疗需求,例如为儿科患者调整剂量、特殊药物组合、为对特定辅料过敏的患者提供药物,以及为制药行业未提供的罕见病药物提供药物。本文综述提供了此类应用的实例。坚持服药是一个关键的公共卫生问题,因为不坚持药物治疗与不良后果及更高的患者护理成本相关。坚持治疗是降低发病率和死亡率以及优化财政资源使用的关键因素。药物配制在促进药物依从性方面的作用尚未得到充分利用。定制化可能是对治疗开始的一种积极强化,而在药房环境中,实施和持续性也可能得到促进。然而,文献中缺乏关于配制在促进依从性方面影响的研究。此类研究结果可为包括适当监管框架、药剂师培训以及向医疗保健从业者提供信息在内的卫生政策提供支持。